The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2015
Filed:
Mar. 16, 2012
Stephen T. Wrobleski, Flemington, NJ (US);
Jagabandhu Das, Mercerville, NJ (US);
Jingwu Duan, Yardley, PA (US);
Junqing Guo, Princeton, NJ (US);
John Hynes, Washington Crossing, PA (US);
Bin Jiang, Norristown, PA (US);
James Kempson, Princeton, NJ (US);
Shuqun Lin, Newtown, PA (US);
Zhonghui LU, King of Prussia, PA (US);
William J. Pitts, Newtown, PA (US);
Steven H. Spergel, Warrington, PA (US);
Hong Wu, New Hope, PA (US);
Bingwei Vera Yang, Belle Mead, NJ (US);
Stephen T. Wrobleski, Flemington, NJ (US);
Jagabandhu Das, Mercerville, NJ (US);
Jingwu Duan, Yardley, PA (US);
Junqing Guo, Princeton, NJ (US);
John Hynes, Washington Crossing, PA (US);
Bin Jiang, Norristown, PA (US);
James Kempson, Princeton, NJ (US);
Shuqun Lin, Newtown, PA (US);
Zhonghui Lu, King of Prussia, PA (US);
William J. Pitts, Newtown, PA (US);
Steven H. Spergel, Warrington, PA (US);
Hong Wu, New Hope, PA (US);
Bingwei Vera Yang, Belle Mead, NJ (US);
Bristol-Myers Squibb Company, Princeton, NJ (US);
Abstract
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.